Metraipolis › archive › dc_f5da6169fcff

Is Ready-To-Use AbobotulinumtoxinA More Effective Than OnabotulinumtoxinA for Glabellar Lines? A Randomized, Controlled, Triple-Blinded Clinical Trial — Europe PMC PMID:41889091

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41889091
DOI
10.1111/jocd.70816
License (as archived)
solo-consultazione
Archived
2026-11-03T13:09:11.064Z
SHA-256 of the archived text
e74dad893c3f7e0c6cfda8e1dc4deb7318b1a0297a5efb7d3600454a4e79e172
Stable URL of this page
https://metraipolis.com/documento/dc_f5da6169fcff

How to cite

Is Ready-To-Use AbobotulinumtoxinA More Effective Than OnabotulinumtoxinA for Glabellar Lines? A Randomized, Controlled, Triple-Blinded Clinical Trial — Europe PMC PMID:41889091 — Europe PMC (en), https://europepmc.org/article/MED/41889091 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f5da6169fcff (Metraipolis archive dc_f5da6169fcff, sha256 e74dad893c3f7e0c6cfda8e1dc4deb7318b1a0297a5efb7d3600454a4e79e172)
BibTeX
@misc{dcf5da6169fcff,
  title = {Is Ready-To-Use AbobotulinumtoxinA More Effective Than OnabotulinumtoxinA for Glabellar Lines? A Randomized, Controlled, Triple-Blinded Clinical Trial — Europe PMC PMID:41889091},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41889091},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f5da6169fcff; sha256 e74dad893c3f7e0c6cfda8e1dc4deb7318b1a0297a5efb7d3600454a4e79e172},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41889091. Agents can read the archived copy with the MCP tool read_document.